Profiel
Einat Brill-Almon worked as Director of Research & Development at Medgenics Medical (Israel) Ltd. from 2001 to 2004.
She then worked at Protalix Biotherapeutics, Inc. from 2004 to 2022, where she held the position of Senior Vice President & Chief Development Officer from 2020 to 2022.
Prior to that, she was Senior Vice President of Product Development at Protalix Ltd. Dr. Brill-Almon received her undergraduate degree from The Hebrew University of Jerusalem and her graduate and doctorate degrees from the Weizmann Institute of Science.
Eerdere bekende functies van Einat Brill-Almon
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01-04-2022 |
Medgenics Medical (Israel) Ltd.
Medgenics Medical (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops protein delivery technology | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 |
Protalix Ltd. | Corporate Officer/Principal | - |
Opleiding van Einat Brill-Almon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Medgenics Medical (Israel) Ltd.
Medgenics Medical (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops protein delivery technology | Commercial Services |
Protalix Ltd. |
















